Medinol Claims Old Partner Infringes Stent Patents

Law360, New York (February 22, 2006, 12:00 AM EST) -- In an attempt to keep a former partner from sinking its teeth into the $5 billion global coronary stent market, Israel’s Medinol Ltd. filed a new legal claim Monday against Boston Scientific Corp. that alleges its stents violate three of Medinol’s patents.

Medinol, which won a $750 million settlement against Boston Scientific in a breach of contract suit last September, filed its patent claim with the World Intellectual Property Organization in Geneva before an arbitration body, according to a Medinol attorney.

Medinol asserts Boston Scientific’s Liberte...
To view the full article, register now.